What is BioSynth?

BioSynth is a revolutionary medical project that combines artificial intelligence (AI) and genetic algorithm therapy to promote innovation and breakthroughs in the medical field. By utilizing advanced AI technology and genetic algorithms, BioSynth is committed to developing personalized treatment plans to provide patients with more effective and accurate medical services.

Vision

BioSynth's vision is to tailor the best treatment plan for each patient through AI gene algorithm therapy, and to achieve personalized treatment and precision medicine in the medical field. We are committed to building an innovative platform that combines artificial intelligence and medicine to bring new medical experiences and breakthroughs to patients and medical professionals.

Introduction to AI Gene Algorithm Therapy

AI gene algorithm therapy is a method that uses genomic data and artificial intelligence technology to customize personalized treatment plans. By analyzing the patient's genomic data, the genetic algorithm can identify the patient's genetic characteristics, disease risk, and drug response, thereby tailoring the best treatment plan for each patient.

WhitePaper

BioSynth Project Architecture

The technical architecture of the BioSynth project is based on advanced artificial intelligence, genetic algorithms and blockchain technology to build a comprehensive medical information platform.

Artificial Intelligence Module

Used to analyze patients' genetic data and medical information and develop personalized treatment plans.

Genetic algorithm engine

Enable generation and optimization of personalized treatment plans based on genomics data.

Blockchain Platform

Used to securely store and manage medical data, ensuring data security, transparency and non-tamperability.

Front-end application

Provide a user-friendly interface to make it easy for patients and healthcare professionals to use the platform features.

Application scenarios of BioSynth platform

BioSynth in Medical Diagnosis

BioSynth uses image recognition technology and natural language processing technology to provide doctors with powerful auxiliary tools to help them diagnose diseases more accurately by analyzing massive amounts of medical data.
Application of BioSynth in Drug Development

BioSynth can predict the efficacy and side effects of drugs by analyzing massive amounts of bioinformatics data, providing researchers with targeted research and development directions.
Application of BioSynth in Personalized Medicine

BioSynth technology plays a core role in personalized medicine. By analyzing an individual's genetic information, lifestyle habits, medical history and other multi-dimensional data, BioSynth can provide patients with customized treatment plans and health management services.
BioSynth in Telemedicine

BioSynth technology not only improves the accessibility of telemedicine services, but also brings patients a more convenient and efficient medical experience.

Token Economic Model

Token issuance and distribution:
Token symbol: AIG
Total supply: 600 million AIG
Token distribution:

Foundation holding: 10%
Team operation holding: 5%
Development team holding: 30%
STO issuance + circulation share: 40%
Marketing airdrop share: 15%

About the Team

The BioSynth team and advisory group have interdisciplinary expertise and experience and will work together to promote the development and innovation of BioSynth projects in the medical field.

Bob Williams（Chief Executive Officer）

Bob holds a PhD in Computer Science and has served as an executive in several medical technology companies. She has extensive experience in blockchain and artificial intelligence technologies and is committed to applying technological innovation to the medical industry.

John Smith（Chief Technology Officer）

John holds a master's degree and has extensive experience in artificial intelligence and genetic algorithms. He has worked as a senior data scientist in a well-known medical technology company and has in-depth research on the application of AI in the medical field.

Emily Johnson（Blockchain development engineer）

Emily is a senior blockchain development engineer with many years of experience in blockchain development. She has served as a core developer in multiple blockchain projects and is familiar with smart contract development and blockchain security.

Michael Davis（Data Scientist）

Michael is a data scientist focusing on genomics data analysis and medical information processing. He has deep expertise in big data analysis and machine learning, and provides technical support for data processing and analysis of the BioSynth project.